BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND LDH AND Prognosis
256 results:

  • 1. [Characteristics and prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic leukemia/Lymphoma from Multicenter].
    Li ZH; Luo L; Yang P; Li Y; Zou DH; Gao CJ; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):120-124. PubMed ID: 38387909
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.
    Paterno G; Palmieri R; Tesei C; Nunzi A; Ranucci G; Mallegni F; Moretti F; Meddi E; Tiravanti I; Marinoni M; Page C; Fagiolo S; Buzzatti E; Secchi R; Gurnari C; Maurillo L; Buccisano F; Venditti A; Del Principe MI
    Thromb Res; 2024 Apr; 236():30-36. PubMed ID: 38387301
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.
    Ahmed HA; Nafady A; Ahmed EH; Hassan EEN; Soliman WGM; Elbadry MI; Allam AA
    Ann Hematol; 2024 Mar; 103(3):781-792. PubMed ID: 37946029
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Richter transformation - retrospective treatment outcomes analysis in Polish Adult leukemia Study Group.
    Sośnia O; Pruszczyk K; Danecki M; Wąsik-Szczepanek E; Tryc-Szponder J; Iskierka-Jażdżewska E; Majeranowski A; Krzemień H; Bołkun Ł; Paszkiewicz-Kozik E; Drozd-Sokołowska J; Kwiatkowski J; Wiśniewska-Organek D; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Budziszewska B; Jamroziak K; Hus I; Lech-Marańda E; Puła B
    Leuk Lymphoma; 2024 Feb; 65(2):175-186. PubMed ID: 37921067
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Effects of Cytokines on Early Death in Patients with Newly Diagnosed Acute Promyelocytic leukemia].
    Zhao SX; Ge YY; Li ZZ; He HP; Shen CM; Shi KQ; Yang TH; DU YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1315-1321. PubMed ID: 37846678
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic leukemia Patients.
    Aref S; El Tantawy A; Aref M; El Agdar M; Ayed M
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2439-2444. PubMed ID: 37505778
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic leukemia.
    Aref S; El Tantawy A; Gouda E; Ayed M
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):1943-1948. PubMed ID: 37378922
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chromosomal aberrations and prognostic analysis of secondary acute myeloid leukemia-a retrospective study.
    Song M; Zhang T; Yang D; Xiao H; Wang H; Ye Q; Zhai Z
    PeerJ; 2023; 11():e15333. PubMed ID: 37214104
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinical Characteristics and Survival Analysis of Patients with Chronic Myelomonocytic leukemia].
    Wang JY; Chen JF; Wang SF; Guo QH; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):476-482. PubMed ID: 37096522
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression pattern of
    Chu X; Wu D; Zhang C; Hu S
    Scand J Clin Lab Invest; 2023 Jul; 83(4):207-211. PubMed ID: 37093849
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia].
    Ma L; Zhao T; Chen YY; Jiang H; Xu LP; Zhang XH; Wang Y; Sun YQ; Mo XD; Huang XJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):124-131. PubMed ID: 36948866
    [No Abstract]    [Full Text] [Related]  

  • 12. Clinical outcomes and characteristics of patients with
    Zhang L; Chen K; Li Y; Chen Q; Shi W; Ji T; Tao H; He Z; Wang C; Yu L
    Hematology; 2023 Dec; 28(1):2181773. PubMed ID: 36892252
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comprehensive analysis of clinicalf eatures, treatment options, overall survival, and prognostic factors in lymphoma cell leukemia patients: A retrospective study.
    Kang Y; Fang K; Wang M
    J Cancer Res Ther; 2022 Dec; 18(7):1961-1966. PubMed ID: 36647956
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular characterization of AML-MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC-defining criteria, TP53 allelic state, or TP53 variant allele frequency.
    Zhao D; Eladl E; Zarif M; Capo-Chichi JM; Schuh A; Atenafu E; Minden M; Chang H
    Cancer Med; 2023 Mar; 12(6):6511-6522. PubMed ID: 36394085
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
    Kittai AS; Huang Y; Beckwith KA; Bhat SA; Bond DA; Byrd JC; Goldstein D; Grever MR; Miller C; Rogers KA; Yano M; Woyach JA
    Am J Hematol; 2023 Jan; 98(1):56-65. PubMed ID: 36216791
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
    Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
    [No Abstract]    [Full Text] [Related]  

  • 17. PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic Lymphoma.
    Zhao J; Guo X; Ma L; Zheng M; Guan T; Su L
    Contrast Media Mol Imaging; 2022; 2022():6057017. PubMed ID: 36072622
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk stratification by 30-day prognostic factors of clinical outcomes after granulocyte transfusion in acute myeloid leukemia: A single-center retrospective study.
    Yoo J; Cho HS; Yoon JH; Cho BS; Kim HJ; Lee DG; Jekarl DW; Kim M; Oh EJ; Park YJ; Kim Y
    PLoS One; 2022; 17(8):e0273827. PubMed ID: 36040987
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [FLT3-ITD and NPM1 mutation positive acute myeloid leukemia with cuplike blasts mimicking acute promyelocytic leukemia].
    Aoyama K; Yamasaki Y; Mouri F; Maehiro Y; Takaki Y; Oya S; Nakamura T; Morishige S; Yamaguchi M; Nagafuji K
    Rinsho Ketsueki; 2022; 63(7):764-769. PubMed ID: 35922945
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria.
    Yan W; Fan H; Xu J; Liu J; Li L; Du C; Deng S; Sui W; Hao M; Yi S; Zou D; Qiu L; Xu Y; An G
    Leuk Lymphoma; 2022 Dec; 63(12):2955-2964. PubMed ID: 35819882
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.